Clinical Trials

    A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy (FORTITUDE-HCM)

    Investigator: Sherif Nagueh

    Study Coordinator: Alharith Humadi

    Status: Open Not Enrolling

    ClinicalTrials.gov Number: NCT07023614

    Phone: 346.238.4551

    Protocol Number: PRO00041238

    Description


    FORTITUDE-HCM is a global, multicenter, double-blind, parallel-group, placebo-controlled Phase 2b study that will assess the efficacy and safety of ninerafaxstat compared to placebo on top of Standard of Care in patients with symptomatic nHCM NCT07023614